LAZCLUZE vs LORBRENA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. LAZCLUZE and LORBRENA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	LAZCLUZE	LORBRENA
Rating	New	64/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	LAZERTINIB MESYLATE	LORLATINIB
Manufacturer	Janssen Biotech	Pfizer
Dosage forms	Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Lung Neoplasms	—

lazcluze lorbrena

Rating

New

64/100

Pharmacy pays

—

Type

Active ingredient

LAZERTINIB MESYLATE

LORLATINIB

Manufacturer

Janssen Biotech

Pfizer

Dosage forms

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Lung Neoplasms

—

Frequently asked questions

What is the difference between Lazcluze and Lorbrena?

Lazcluze contains Lazertinib Mesylate, while Lorbrena contains Lorlatinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.